Authors: Aryan Kulkarani, Abhishek Sinha, Rupa Kulkarani
Abstract: In clinical practise, this entails having a well-organized Pharmacovigilance system in place. Pharmacovigilance is a crucial activity for monitoring drug-related concerns after they have been sold in the "real world." Pharmacovigilance and all drug-related concerns are critical for everybody whose life is affected in some manner by medical treatments. An organised Adverse Drug Reaction monitoring programme is one mechanism for more actively detecting ADRs and, as a result, improving patient care quality. The numerous processes for evaluating and monitoring the safety of medications in clinical use are critical for preventing or lessening damage to patients and enhancing public health. Adverse drug reactions (ADRs) have a significant influence on public health, decreasing patients' quality of life and laying a significant financial burden on health care systems at a time when many are under financial duress. All healthcare practitioners have a role to play in balancing the advantages and hazards of a drug. Once a medicine is offered to the public, determining its safety is the joint duty of all those involved in the prescription process, including patients. Healthcare practitioners play an important role in collecting and reporting suspected ADRs so that regulatory bodies are notified of potential safety issues, allowing for early and appropriate action. Pharmacovigilance is a crucial activity for monitoring drug-related concerns after they have been sold in the "real world." Pharmacovigilance and all drug-related concerns are critical for everybody whose life is affected in some manner by medical treatments. This study discusses many issues of monitoring and evaluating adverse medication reactions in clinical settings.
Keywords: Drug, Adverse drug reactions, Pharmacovigilance.
Full Issue
| View or download the full issue | PDF 6-21 |